Web Results

Plerixafor

en.wikipedia.org/wiki/Plerixafor

Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients ... Trade names, Mozobil. AHFS/Drugs.com · Consumer Drug ...

Mozobil

www.mozobil.com/

Official site from Genzyme Corporation. Contains consumer and prescribing information.

Learn more about Mozobil | Mozobil (plerixafor injection)

www.mozobil.com/patient

Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

About Mozobil | Mozobil (plerixafor injection)

www.mozobil.com/healthcare/about

Learn more about Mozobil (plerixafor injection). The Mozobil Professional website is designed to help healthcare professionals care for their patients with ...

Mozobil (plerixafor) injection label - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf

MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ... Initiate Mozobil treatment after the patient has received G-CSF once daily for 4 days.

Mozobil New FDA Drug Approval | CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/1009/mozobil-plerixafor-injection

Mozobil (plerixafor injection): For the treatment of non-Hodgkin's lymphoma and multiple myeloma. New approved drug details including side effects, uses and ...

European Medicines Agency - Find medicine - Mozobil

www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001030/human_med_000910.jsp&mid=WC0b01ac058001d124

Next tab ». This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) ...

MOZOBIL® (plerixafor) Injection, for subcutaneous use Prescribing ...

products.sanofi.us/Mozobil/mozobil.html

Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells ...

FDA Approves Genzyme's Mozobil | Genzyme Corporation Online ...

news.genzyme.com/press-release/fda-approves-genzymes-mozobil

Dec 15, 2008 ...Mozobil is an important advancement in the treatment of patients with certain types of cancer who require a stem cell transplant,” said John F.

Mozobil 20 mg/ml solution for injection - Summary of Product ...

www.medicines.org.uk/emc/medicine/22187/SPC/Mozobil 20 mg ml solution for injection

Apr 1, 2015 ... Mozobil is indicated in combination with granulocyte-colony stimulating factor (G- CSF) to enhance mobilisation of haematopoietic stem cells to ...

More Info

Why Mozobil? | Mozobil (plerixafor injection)

www.mozobil.com

Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

Mozobil (plerixafor) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com

Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions ...

Mozobil (Plerixafor Injection) Drug Information: Description, User ...

www.rxlist.com

Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...